On March 11th, 2026, the Los Angeles Times published an article exploring geroscience, highlighting how researchers are shifting the focus from treating diseases individually to addressing the underlying biological processes to prevent or delay age-related disease and extend healthspan.
The article touched on advances in the field of aging research, the potential social and economic benefits of investing in geroscience to extend healthspan, and the need for validated biomarkers of aging to enable clinical trials that can target the process of aging itself.
AFAR applauds the LA Times for this thorough and accurate coverage of geroscience and its promise to extend healthspan.
Learn more about the biological processes of aging, or Hallmarks of Aging, here.
For more insights into the potential benefits of investing in geroscience, watch our recent webinar, “The Potential of Geroscience: from Economic Gains to Social Returns and Ethical Concerns” here.
Read the full article “Geroscience: The Biological Mechanisms of Aging and Human Longevity” here.
